Ondansetron
NDC 43063-273, Ondansetron, tablet, orally disintegrating, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 43063-273
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078152
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43063-273 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43063-273-04 | 43063027304 | 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-273-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d117de5f-64e5-464c-b782-de0f07e66c8e
Use it
Look up 43063-273 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43063-273 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43063-273. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.